Geneoscopy Appoints Amit Bhalla as Chief Financial Officer to Advance Strategic Growth and Support Commercialization Efforts (Geneoscopy)

Geneoscopy has appointed veteran healthcare strategist Amit Bhalla as Chief Financial Officer to steer its financial and commercial trajectory amid rapid expansion. Bhalla, who brings over 25 years of healthcare finance experience—including leadership roles at Sampled and Becton Dickinson—joins the team as the company readies for the commercial launch of ColoSense®, its RNA-based, noninvasive colorectal cancer screening test approved by the FDA in May 2024.